कृपया अन्य खोज का प्रयास करें
Aroa Biosurgery Limited engages in the development, manufacture, and sale of medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; Myriad Morcells Fine; and OviTex and OviTex PRS, a reinforced bioscaffolds for use in hernia repair and abdominal wall reconstruction, as well as breast reconstruction. The company also offers Symphony, a combination cellular and tissue product, indicated for the regeneration of functional tissue in complex wounds. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Brian Ward | - | 2007 | Founder, CEO, MD & Executive Director |
John Richard Pinion | 55 | 2015 | Independent Non-Executive Director |
James Neil McLean | - | 2011 | Independent Non-Executive Chairperson |
Philip McCaw | - | 2008 | Non-Executive Director |
John Flower Diddams | 74 | 2019 | Independent Non-Executive Director |
Catherine Mohr | 55 | 2022 | Independent Non-Executive Director |
Darla Hutton | - | 2024 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है